Who will be there

Presenter/Chair
Marc D. Cohen, MD
National Jewish Medical and Research Center

Presenters

Allan Gibofsky, MD
Weill Medical College of Cornell University
Eric M. Ruderman, MD
Northwestern University Feinberg School of Medicine
Alvin F. Wells, MD, PhD
Rosalind Franklin University of Medicine and Sciences

What will be the focus

This CME-accredited symposium on rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis discusses mechanisms for increased risk of comorbidities, the cardiovascular connection, safety issues with biologics, and up-to-date efficacy data on treatments in biologic-naïve and biologic-failure patients.

Program Agenda

Learning Objectives

Apply clinical measurement tools and imaging techniques to assess rheumatoid arthritis (RA) disease status
Discuss the clinical evidence and impact of biologic treatment plans in RA
Implement strategies to manage biologic therapy in patients with RA who experience an inadequate response
Describe the clinical presentation of psoriatic arthritis (PsA) and ankylosing spondylitis (AS)
Incorporate diagnostic and assessment methods for measuring disease activity in PsA and AS
Analyze the latest evidence on the benefits and limitations of biologic therapy in PsA and AS
Compare the occurrence of infection and malignancy inherently found in RA with those patients who are treated with
biologic and/or DMARD therapy
Describe potential mechanisms for increased risk of comorbidities in RA
Examine the cardiovascular connection in the patient with RA

CME Accreditation

The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

The University of Kentucky College of Medicine requires that speakers disclose significant relationships with commercial companies whose product or services are discussed in educational presentations. Disclosures will be included in the activity materials.

Special Services

The University of Kentucky College of Medicine and North American Center for Continuing Medical Education (NACCME) fully comply with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact John Savage, Director, Medical Education, NACCME at 609-371-1137.

The University of Kentucky is an Equal Opportunity University.

The When and Where

1 pm, Wednesday,
October 29, 2008
San Francisco Marriott
Yerba Buena Salon 8

This symposium will be conducted at the conclusion of the 2008 Annual Scientific Meeting of the American College of Rheumatology.

This symposium is sponsored by the University of Kentucky College of Medicine and is supported by educational grants from Genentech, Inc and Biogen Idec Inc, Abbott Laboratories, Centocor, Inc, UCB, Inc, Bristol-Myers Squibb Company, and Amgen Inc and Wyeth Pharmaceuticals. This is not an official program of the American College of Rheumatology.